SPDR S&P Kensho Future Security ETF (FITE) Stock Price

84.43 ▲ +2.3598 (+2.88%)
Open: 83.70 Vol: 0 Day's range: 83.43 - 84.43 Mar 31, 12:39 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
FITE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 83.50▲ 83.50▲ 83.50▲ 85.48▼ 86.80▼
MA10 84.55▼ 84.55▼ 84.55▼ 87.02▼ 88.21▼
MA20 86.73▼ 86.70▼ 86.74▼ 88.44▼ 88.01▼
MA50 88.47▼ 88.58▼ 88.58▼ 90.02▼ 81.83▲
MA100 89.15▼ 89.78▼ 90.34▼ 88.16▼ 72.10▲
MA200 90.61▼ 89.36▼ 89.11▼ 84.50▼ 60.09▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.319▼ -0.323▼ -0.323▼ -0.595▼ -1.202▼
RSI 40.286▼ 40.729▼ 40.855▼ 40.669▼ 46.044▼
STOCH 16.495▼ 16.495▼ 16.495▼ 25.537     22.759    
WILL %R -68.191     -68.520     -68.520     -70.795     -83.536▼
CCI -40.488     -41.487     -41.487     -150.953▼ -150.037▼
Latest Filters Detected On FITE
CDL $FITE Harami Candlestick Pattern Detected Set Alert
SPDR S&P Kensho Future Security ETF News
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
Monday, March 30, 2026 06:37 AM
Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company VetbiolixRamat Gan, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite ...
Can-Fite BioPharma Ltd.: Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free ...
Thursday, March 26, 2026 07:12 AM
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting ...
Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer ...
Thursday, March 26, 2026 06:48 AM
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today ...
FITE historical stock data
date open high low close volume
31/03/26 83.70 84.43 83.43 84.43 1,998
30/03/26 85.47 85.47 81.86 82.0702 9,457
27/03/26 86.63 86.63 84.01 84.2386 14,067
26/03/26 88.44 89.60 87.075 87.16 18,500
25/03/26 89.29 90.64 89.29 89.508 7,000
24/03/26 88.26 88.76 87.75 88.037 11,800
23/03/26 88.34 90.00 87.77 89.214 14,800
20/03/26 88.98 88.98 86.66 87.19 8,343
19/03/26 88.00 89.72 87.52 89.21 13,720
18/03/26 90.34 90.66 89.10 89.10 7,000
Quote Details
52wk Low:54.00
52wk High:97.47
Vol:0
Avg Vol(3m):262.5K
1Y Chng:+37.26%
1M Chng:-6.01%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00